Jeffrey G. Black's Net Worth

$12.7 Million

Estimate Recalculated Jul 2, 2024 04:45PM EST

Who is Jeffrey G. Black?

Jeffrey G. Black has an estimated net worth of $12.7 Million. This is based on reported shares across multiple companies, which include Alphatec Holdings, Inc., Apollo Endosurgery, Inc., STANDARD BIOTOOLS INC., and VERENIUM CORP.

SEC CIK

Jeffrey G. Black's CIK is 0001449439

Past Insider Trading and Trends

2009 was Jeffrey G. Black's most active year for acquiring shares with 10 total transactions. Jeffrey G. Black's most active month to acquire stocks was the month of July. 2013 was Jeffrey G. Black's most active year for disposing of shares, totalling 9 transactions. Jeffrey G. Black's most active month to dispose stocks was the month of September. 2021 saw Jeffrey G. Black paying a total of $1,522,250.00 for 375,000 shares, this is the most they've acquired in one year. In 2021 Jeffrey G. Black cashed out on 32,000 shares for a total of $523,830.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Alphatec Holdings, Inc. (ATEC) Snapshot price: $16.41

EVP & CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.12%
-7.00K
$16.69
-$116,830.00
620.77K
Scheduled
Mar 9
Form 4
-3.83%
-25.00K
$16.28
-$407,000.00
627.77K
Scheduled
Feb 16
Form 4
-0.76%
-5.00K
$6.42
-$32,100.00
652.77K
Aug 11
Form 4
-1.34%
-8.93K
$5.03
-$44,912.87
657.77K
Scheduled
Aug 4
Form 4
-3.44%
-23.77K
$4.06
-$96,522.44
666.7K
May 14
Form 4
+35.04%
179.18K
—
—
690.47K
Apr 22
Form 4
+1.19%
6K
$3.93
$23,564.28
511.3K
Apr 6
Form 4
-1.28%
-6.56K
$5.08
-$33,307.22
505.3K
Scheduled
Mar 10
Form 4
-1.71%
-8.93K
$4.75
-$42,368.10
511.86K
Scheduled
Aug 2
Form 4
+194.16%
343.75K
—
—
520.79K
May 13
Form 4
+136.05%
102.04K
—
—
177.04K
Jul 30
Form 4
+46.69%
15.87K
—
—
49.87K
May 17
Form 4
—
0
—
—
0
Mar 8
Form 4
+17.24%
5K
$1.80
$9,000.00
34K
Aug 17
Form 4
+5.33%
4K
$1.75
$7,000.00
79K
Aug 16
Form 4
—
0
—
—
0
Jul 26
Form 4
∞
25K
—
—
25K
Jul 14
Form 4
∞
75K
—
—
75K
Mar 29 - Mar 31
Form 4
—
0
—
—
0
Mar 6
Form 3
—
0
—
—
0
No matching records found

Apollo Endosurgery, Inc. No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-335.33K
—
—
0
Apr 4
Form 4
-4.33%
-15.06K
$6.46
-$97,287.60
332.65K
Nov 4
Form 4
-1.75%
-6.19K
$6.46
-$39,987.40
347.71K
Aug 5
Form 4
+33.55%
88.9K
—
—
353.9K
Jun 14
Form 4
+17.78%
40K
$5.73
$229,100.00
265K
Feb 25 - Mar 1
Form 4
∞
225K
$8.75
$218,750.00
225K
Aug 9 - Aug 11
Form 3
—
0
—
—
0
No matching records found

STANDARD BIOTOOLS INC. (LAB) Snapshot price: $2.345

SVP & Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+250.34%
300K
—
—
419.84K
May 20
Form 4
+39.37%
33.85K
$2.54
-$47,698.66
119.84K
May 15
Form 4
∞
85.98K
$2.25
$193,578.42
85.98K
May 18 - May 19
Form 4
—
0
—
—
0
May 15
Form 3
—
0
—
—
0
No matching records found

VERENIUM CORP No price found

Sr. Vice President & CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.13K
$4.00
-$24,500.00
0
Oct 31
Form 4
—
0
—
—
0
Aug 1
Form 4
—
0
—
—
0
Aug 2
Form 4
+44.12%
1.88K
$1.99
$3,751.75
6.13K
Aug 15 - Aug 16
Form 4
—
0
—
—
0
Feb 24
Form 4
—
0
—
—
0
Sep 7
Form 4
∞
4.25K
$2.78
$11,827.50
4.25K
Aug 16 - Aug 17
Form 4/A
—
0
—
—
0
Nov 12
Form 4
—
0
—
—
0
Dec 11
Form 4
—
0
—
—
0
Nov 12
Form 4
-100.00%
-1.67K
$0.63
-$1,050.21
0
Scheduled
Dec 20
Form 3
—
0
—
—
0
No matching records found